BARR PHARMACEUTICALS INC (BRL) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 360 transactions totaling $71.9M, demonstrating a bearish sentiment with -$71.9M in net insider flow. The most recent transaction on Dec 23, 2008 involved a transaction of 2,089 shares valued at $0.
No significant insider buying has been recorded for BRL in the recent period.
No significant insider selling has been recorded for BRL in the recent period.
Based on recent SEC filings, insider sentiment for BRL is bearish with an Insider Alignment Score of 0/100 and a net flow of -$71.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at BARR PHARMACEUTICALS INC (BRL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading BRL stock, having executed 360 transactions in the past 90 days. The most active insider is Paul Bisaro (Executive), who has made 73 transactions totaling $36.6M.
Get notified when executives and directors at BRL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 23, 2008 | Frankovic Richard | Executive | Disposition | 2,089 | $N/A | $0 | |
| Dec 23, 2008 | Stephan George | Executive | Disposition | 11,875 | $N/A | $0 | |
| Dec 23, 2008 | N. Chefitz Harold | Executive | Disposition | 26,250 | $N/A | $0 | |
| Dec 23, 2008 | Sawyer Timothy | Executive | Disposition | 652.15 | $N/A | $0 | |
| Dec 23, 2008 | Mckee William | Executive | Disposition | 8,977 | $N/A | $0 | |
| Dec 23, 2008 | Bogda Michael | Executive | Disposition | 17,918 | $N/A | $0 | |
| Dec 23, 2008 | Downey Bruce | Executive | Disposition | 426,654 | $N/A | $0 | |
| Dec 23, 2008 | Mundkur Christine | Executive | Disposition | 5,406 | $N/A | $0 | |
| Dec 23, 2008 | Killion Frederick | Executive | Disposition | 11,589 | $N/A | $0 | |
| Dec 23, 2008 | Kirk Sigurd | Executive | Disposition | 1,064 | $N/A | $0 | |
| Dec 17, 2008 | Mckee William | Executive | Gift | 600 | $66.49 | $39.9K | |
| Dec 16, 2008 | Gilmore James III | Executive | Sale | 200 | $65.14 | $13.0K | |
| Dec 16, 2008 | Gilmore James III | Executive | Sale | 300 | $65.12 | $19.5K | |
| Dec 16, 2008 | Gilmore James III | Executive | Sale | 1,600 | $65.11 | $104.2K | |
| Dec 16, 2008 | Gilmore James III | Executive | Sale | 200 | $65.11 | $13.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 216 | $71.9M | 61.0% |
Exercise(M) | 84 | $27.0M | 22.9% |
Exercise (Options)(X) | 35 | $11.3M | 9.6% |
Gift(G) | 14 | $7.4M | 6.3% |
Award(A) | 1 | $301.9K | 0.3% |
Disposition(D) | 10 | $0 | 0.0% |
Insider selling pressure at BARR PHARMACEUTICALS INC has increased, with 18 insiders executing 360 transactions across all time. Total sales of $71.9M significantly outpace purchases of $0, resulting in a net outflow of $71.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.